139 related articles for article (PubMed ID: 33976691)
1. Iatrogenic Retinal Penetration from Intravitreal Injections.
Kishore K; McGowan DS; Hanebrink KA
Case Rep Ophthalmol; 2021; 12(1):248-253. PubMed ID: 33976691
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Park DH; Shin JP; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
[TBL] [Abstract][Full Text] [Related]
4. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
[TBL] [Abstract][Full Text] [Related]
5. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry.
Gabrielle PH; Nguyen V; Arnould L; Viola F; Zarranz-Ventura J; Barthelmes D; Creuzot-Garcher C; Gillies M;
Ophthalmol Retina; 2022 Nov; 6(11):1044-1053. PubMed ID: 35589075
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration.
Papadopoulou DN; Mendrinos E; Mangioris G; Donati G; Pournaras CJ
Ophthalmology; 2009 Sep; 116(9):1755-61. PubMed ID: 19560206
[TBL] [Abstract][Full Text] [Related]
7. [Iatrogenic retinal defects after intravitreal operative drug injections].
Märker DA; Radeck V; Lehmann F; Barth T; Helbig H; Eter N; Alten F; Clemens CR
Ophthalmologie; 2024 Feb; 121(2):129-134. PubMed ID: 38214731
[TBL] [Abstract][Full Text] [Related]
8. [Interest of optical coherence tomography performed immediately before intravitreal injection of anti-VEGF in exudative AMD].
Moyal L; Cohen SY; Pedinielli A; Semoun O; Lalloum F; Jung C; Souied E
J Fr Ophtalmol; 2015 Sep; 38(7):573-9. PubMed ID: 25997681
[TBL] [Abstract][Full Text] [Related]
9. [Neovascular recurrences in 42 treatment-naive eyes with neovascular age-related macular degeneration (AMD) followed for over 2 years].
Bodénès F; Massé H; Lebreton O; Weber M
J Fr Ophtalmol; 2021 May; 44(5):626-631. PubMed ID: 33840491
[TBL] [Abstract][Full Text] [Related]
10. [Complications of intravitreal injections--own experience].
Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
[TBL] [Abstract][Full Text] [Related]
11. Rhegmatogenous Retinal Detachment after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor.
Storey PP; Pancholy M; Wibbelsman TD; Obeid A; Su D; Borkar D; Garg S; Gupta O
Ophthalmology; 2019 Oct; 126(10):1424-1431. PubMed ID: 31042567
[TBL] [Abstract][Full Text] [Related]
12. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
[TBL] [Abstract][Full Text] [Related]
13. Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.
Higashide T; Murotani E; Saito Y; Ohkubo S; Sugiyama K
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):603-10. PubMed ID: 22116499
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Rhegmatogenous Retinal Detachment after Intravitreal Therapy in Neovascular Age-Related Macular Degeneration.
Mammo DA; Ringeisen AL; Parke DW
Ophthalmol Retina; 2020 Oct; 4(10):973-978. PubMed ID: 32651157
[TBL] [Abstract][Full Text] [Related]
15. Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.
Day S; Acquah K; Mruthyunjaya P; Grossman DS; Lee PP; Sloan FA
Am J Ophthalmol; 2011 Aug; 152(2):266-72. PubMed ID: 21664593
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and surgical outcomes of rhegmatogenous retinal detachments that develop after intravitreal injections.
Baba T; Miura G; Tatsumi T; Sakurai M; Yamamoto S
Jpn J Ophthalmol; 2021 Jul; 65(4):492-496. PubMed ID: 33745092
[TBL] [Abstract][Full Text] [Related]
17. Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.
Smith JM; Steel DH
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008214. PubMed ID: 26250103
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
19. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.
Goldenberg DT; Giblin FJ; Cheng M; Chintala SK; Trese MT; Drenser KA; Ruby AJ
Retina; 2011 Feb; 31(2):393-400. PubMed ID: 21099453
[TBL] [Abstract][Full Text] [Related]
20. Secondary rhegmatogenous retinal detachment following intravitreal bevacizumab in patients with vitreous hemorrhage or tractional retinal detachment secondary to Eales' disease.
Kumar A; Sehra SV; Thirumalesh MB; Gogia V
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):685-90. PubMed ID: 22169980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
